NASDAQ-GS · traded in Congress
Amgen AMGN
$464.50 +4.08 (+0.89%) Nov 9, 2026 4:25 AM ET
Market value$251.3B
P/E ratio-
Analyst target$440.00
52-week range-
Avg volume2,830,244
Dividend yield2.19%
Chart
Analyst ratings
- 11 buy
- 20 hold
- 6 sell
Low target$230.00
Average target$437.32
High target$536.00
Quarterly financials
| Quarter ended | Revenue | Gross profit | Net income | Net margin |
|---|---|---|---|---|
| $10,365M | - | $3,864M | 37.3% | |
| $10,054M | - | $2,375M | 23.6% | |
| $8,618M | - | $1,819M | 21.1% | |
| $9,866M | - | $1,333M | 13.5% |
Congress trades in AMGN
Members of Congress disclosed 6 transactions in AMGN in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 09/22/2026 | David J. Taylor OH02 | Purchase | $1,001 - $15,000 | 10/1/2026 filing |
| 08/26/2026 | David J. Taylor OH02 | Sale | $1,001 - $15,000 | 9/5/2026 filing |
| 08/26/2026 | David J. Taylor OH02 | Sale | $1,001 - $15,000 | 9/5/2026 filing |
| 06/05/2026 | David J. Taylor OH02 | Purchase | $1,001 - $15,000 | 6/12/2026 filing |
| 04/17/2026 | Maria Elvira Salazar FL27 | Sale | $15,001 - $50,000 | 5/8/2026 filing |
| 03/24/2026 | Maria Elvira Salazar FL27 | Purchase | $15,001 - $50,000 | 4/21/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.
